Navigation Links
Stem Cell Breakthrough Advances Science Without 'Ethical Landmines,' Says Cardinal
Date:11/20/2007

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following statement was released today by Cardinal Justin Rigali of Philadelphia, chairman of the Committee for Pro-Life Activities at the United States Conference of Catholic Bishops:

"Studies published this week in the journals Cell and Science offer new hope for advancing stem cell research and therapies while fully respecting the dignity of human life.

"Scientists in Japan and Wisconsin used four genes to 'reprogram' ordinary adult human cells, creating 'induced pluripotent stem cells' (iPS cells). James Thomson, head of the Wisconsin team and the founder of human embryonic stem cell research, says these cells 'meet the defining criteria' for pluripotent human embryonic stem cells, 'with the significant exception that the iPS cells are not derived from embryos.'

"Thus the goal sought for years through failed attempts at human cloning - the production of 'pluripotent' stem cells that are an exact genetic match to a patient - has been brought within reach by an ethical procedure. This technology avoids the many ethical landmines associated with embryonic stem cell research: it does not clone or destroy human embryos, does not harm or exploit women for their eggs, and does not blur the line between human beings and other species through desperate efforts to make human embryos using animal eggs. Ian Wilmut, head of the team that cloned 'Dolly' the sheep, now says he is abandoning efforts at human 'therapeutic cloning' to pursue this adult cell reprogramming avenue instead, because it is technically superior as well as 'easier to accept socially.'

"I am grateful today for scientists who took up the challenge of finding morally acceptable ways to pursue stem cell research, and for government leaders who have encouraged and funded such avenues. This advance reminds us once again that medical progress and respect for human life are not in conflict; they can and should support and enric
'/>"/>

SOURCE U.S. Conference of Catholic Bishops Secretariat forPro-Life
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
3. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
6. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
7. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
11. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 DUSA Pharmaceuticals...mpany that is developing and marketing Levulan(... focused on patients with common skin conditions, ...utive Officer, will present a corporate overview a... Tuesday, November 10, 2009 at 10:00 a.m. ET at th...
(Date:11/6/2009)... Repossessions and liquidations of... quarter of 2009 declined as compared to similar f...ment,s NasTrac Quarterly Index (NQI). The figures...oth repossessions and orderly liquidations, also i...tion and printing equipment, offering mixed news o...
(Date:11/6/2009)...Newswire-USNewswire/ -- America,s Specialty Medici... mid-market and smaller innovator pharmaceutical c..., the "Affordable Health Care for America Act," in...smaller companies fear that the cumulative effect ...heir efforts to bring new medicines to market. ,...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Hundreds of Genes Could Be Linked to ADHD 50082 1Hundreds of Genes Could Be Linked to ADHD 50082 2Nations first childrens hospital based safety store focuses on child injury prevention 50079 1Nations first childrens hospital based safety store focuses on child injury prevention 50079 2Health care outcome boost needs better studies 50076 1Health care outcome boost needs better studies 50076 2Health care outcome boost needs better studies 50076 3Health care outcome boost needs better studies 50076 4
...Determine Phase 2 Dosing Regimen -, SOUTH SAN FRA...c., a privately held company focused on the develo...or cancer, today announced,updated results from an...inical trial of RAV12, its lead therapeutic antibo...omas. The objectives of the study were to,define t...
...erapy Proven to Significantly Improve Overall Surv...Cancer, WAYNE, N.J. and EMERYVILLE, Calif., Nov. ...maceuticals, Inc. (Nasdaq:,ONXX) today announced t...s,approved a supplemental New Drug Application for...of patients with unresectable hepatocellular,carci...
Other Medicine Technology:Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 2Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
(Date:11/8/2009)... Medicare, improve coverage for all Americans ,...MMARY: Yesterday the United States House of Repre...slation that would strengthen Medicare for seniors...t prices millions of Americans out of affordable h... for America Act (H.R. 3962) makes prescription dr...
(Date:11/8/2009)...me later, doctors say , , SUNDAY, Nov. 8... the NFL this season, sidelining such stars as qua...r. , Officials at the American Podiatric Medica...orts Medicine are warning athletes to take care of...ll and lacrosse. , "Many fall sports athletes l...
(Date:11/8/2009)...s is pleased to announce that it has been successf...ound who recently received an award on the $800 mi...ncludes not only the Veterans Administration, but ...gencies. , New York, NY (...pleased to announce that it has been successful in...
(Date:11/8/2009)... is won," said Dr. Charmaine Yoest. ,, WASHING...f 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlk...n mandates and funding in HR 3962 passed on the Ho...President and CEO Dr. Charmaine Yoest said, "The p...life Americans across this country who have floode...
(Date:11/8/2009)...ire/ -- The following was released today by Randal.... ,, Mr. Terry and his associates from around ...ng by abortion out of any health care bill for mon...t step to victory -- a touchdown in the first quar...Our rejoicing must be tempered by reality. The Sen...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2
...s asked a panel of outside experts to review the s...tent complaints that the fillings may cause health...no evidence to suggest that the fillings were dang... into the matter to see if they agree with the fin...
...e spotlight on the healthcare commission, in charg...their experience with NHS//, which the commission ... The Healthcare Commission has a huge pile of...ealthcare department at the Commission, said: "Cer...
...on between certain bacteria in the gut and autism.... treat autism.// Professor Glenn Gibson of th...gh the results are very preliminary, he is "cautio...e diarrhoea and constipation are common in autisti...
...created new vistas, enabling a panorama of cutti... the race for being the best in the market and off...of the industry’s powerful trident - Pharmaceutica...han the pharmacy week, to laud the efforts of the ...
...o comfortable with the outcome of drug coated hear...ld carry a risk of formation of fatal blood clots....et in 2000 as an upgraded version of bare-metal st...ies are maintained without blocks, after the depos...
... Hyperactivity Disorder (ADHD) cannot sit calmly a...hough mental health professionals and parents are ...disorder is still a controversial topic. The F...heart problems, aggression, and even mania, due to...
Other Medicine News:Health News:Probiotics – a probable treatment for Autis 2Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 2Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 3Health News:Chemistry Over The Counter: Is It Just What The Doctor Ordered? 4Health News:Alternative therapies for ADHD 2Health News:Alternative therapies for ADHD 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: